Frank Zhang is in the clear af­ter Chi­nese au­thor­i­ties con­clude in­ves­ti­ga­tion with­out charges, com­pa­ny says

The for­mer CEO of Gen­Script Biotech, a Hong Kong-list­ed CRO, is now ap­par­ent­ly cleared of any fur­ther in­ves­ti­ga­tions or pros­e­cu­tion in Chi­na.

Ac­cord­ing to the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER